SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001835567-22-000076
Filing Date
2022-11-14
Accepted
2022-11-14 17:19:51
Documents
82
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pear-20220930.htm   iXBRL 10-Q 1961153
2 EX-31.1 CERTIFICATION OF THE CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) exhibit311certificationcmc.htm EX-31.1 10435
3 EX-31.2 CERTIFICATION OF THE CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) exhibit312certificationcgu.htm EX-31.2 10516
4 EX-32.1 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 exhibit32jointcertificatio.htm EX-32.1 5822
10 pear-20220930_g1.jpg GRAPHIC 650556
  Complete submission text file 0001835567-22-000076.txt   9608389

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pear-20220930.xsd EX-101.SCH 52242
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pear-20220930_cal.xml EX-101.CAL 70815
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pear-20220930_def.xml EX-101.DEF 298924
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pear-20220930_lab.xml EX-101.LAB 683533
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pear-20220930_pre.xml EX-101.PRE 464261
76 EXTRACTED XBRL INSTANCE DOCUMENT pear-20220930_htm.xml XML 1197180
Mailing Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109
Business Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109 6469322774
Pear Therapeutics, Inc. (Filer) CIK: 0001835567 (see all company filings)

IRS No.: 854103092 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39969 | Film No.: 221387758
SIC: 8000 Services-Health Services